A methylation-sensitive restriction enzyme (Afe1) method (e.g. 19) was used to quantify site-specific methylation at −30 bp (compared to translation start) of the NR5A1 gene promoter in ovarian tumor tissue from patients with ovarian cancer and in matched normal tissue from the same patients (when available). Here, NR5A1 is linked to ovarian carcinoma.